Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials
-
Published:2001-02
Issue:
Volume:29
Page:4-9
-
ISSN:0093-7754
-
Container-title:Seminars in Oncology
-
language:en
-
Short-container-title:Seminars in Oncology
Subject
Oncology,Hematology
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献